CN Stock MarketDetailed Quotes
603998 Hunan Fangsheng Pharmaceutical
- 11.49
- +0.21+1.86%
Not Open Dec 12 15:00 CST
5.05BMarket Cap18.47P/E (TTM)
11.53High11.23Low86.81KlotVolume11.28Open11.28Pre Close99.27MTurnover1.98%Turnover Ratio27.04P/E (Static)439.12MShares13.5852wk High3.16P/B5.04BFloat Cap6.8752wk Low12.41Limit Up438.71MShs Float20.57Historical High10.15Limit Down2.66%Amplitude3.40Historical Low0.25Dividend TTM11.44Avg Price34.38KlotAsk2.18%Div YieldTTM100Lot Size50.61KlotBid
Hunan Fangsheng Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 10.95%1.35B | 6.44%910.25M | 0.37%438.35M | -9.12%1.63B | -10.51%1.21B | -2.07%855.22M | 3.30%436.76M | 14.36%1.79B | 21.99%1.36B | 19.66%873.31M |
| Operating revenue | 10.95%1.35B | 6.44%910.25M | 0.37%438.35M | -9.12%1.63B | -10.51%1.21B | -2.07%855.22M | 3.30%436.76M | 14.36%1.79B | 21.99%1.36B | 19.66%873.31M |
| Other operating revenue | ---- | 10.76%26.64M | ---- | 43.19%59.09M | ---- | 14.85%24.05M | ---- | 28.50%41.27M | ---- | 58.48%20.94M |
| Total operating cost | 6.95%1.15B | 2.42%772.54M | -1.87%376.02M | -10.50%1.47B | -17.27%1.08B | -9.40%754.32M | -3.25%383.17M | 12.96%1.65B | 26.95%1.3B | 24.18%832.57M |
| Operating cost | -2.43%365.89M | -5.56%248.85M | -16.51%117.54M | -11.38%519.54M | -15.97%375.02M | -9.25%263.49M | -1.87%140.78M | 4.09%586.29M | 10.40%446.29M | 9.22%290.35M |
| Operating tax surcharges | 6.41%23.26M | 5.36%15.57M | 2.43%7.63M | 2.53%29.27M | 5.46%21.85M | 11.39%14.78M | 15.25%7.45M | 17.35%28.55M | 20.75%20.72M | 18.44%13.27M |
| Operating expense | 8.42%547.61M | 5.64%380.34M | 4.98%188.86M | -12.87%657.53M | -19.88%505.09M | -10.06%360.02M | -6.68%179.91M | 19.17%754.62M | 33.46%630.4M | 29.79%400.27M |
| Administration expense | -5.01%103.65M | -16.55%62.63M | -9.53%32.7M | -20.43%149.31M | -3.37%109.12M | 2.14%75.05M | 19.95%36.14M | 11.37%187.65M | 28.13%112.93M | 27.69%73.47M |
| Financial expense | -10.38%6.71M | -8.94%3.8M | 155.35%3.32M | -45.72%10.82M | -82.13%7.49M | -81.54%4.17M | -79.35%1.3M | 12.89%19.93M | 348.02%41.93M | 304.85%22.58M |
| -Interest expense (Financial expense) | 9.30%16.17M | 24.50%11.14M | 111.14%6.29M | -9.35%20.81M | -25.90%14.79M | -26.28%8.94M | -53.88%2.98M | 24.82%22.95M | 114.76%19.97M | 92.27%12.13M |
| -Interest Income (Financial expense) | -37.42%-10.31M | -47.55%-7.8M | -74.06%-4.81M | -124.07%-10.64M | -464.72%-7.5M | -227.20%-5.29M | -397.61%-2.77M | -168.78%-4.75M | -36.22%-1.33M | -66.70%-1.62M |
| Research and development | 80.72%103.39M | 66.68%61.35M | 47.62%25.97M | 53.31%107.93M | 18.83%57.21M | 12.84%36.81M | 4.00%17.59M | 36.96%70.4M | 45.71%48.14M | 48.89%32.62M |
| Credit Impairment Loss | -558.66%-12.31M | -368.32%-7.65M | -180.49%-3.51M | 88.68%-2.56M | 137.05%2.68M | 149.29%2.85M | 450.03%4.36M | -384.68%-22.6M | 14.56%-7.24M | 5.28%-5.78M |
| Asset Impairment Loss | -819.34%-2.09M | -389.37%-287.11K | 103.19%317.47K | -97.97%-2.33M | 51.34%290.93K | -121.17%-58.67K | 112.40%156.24K | 90.13%-1.18M | 130.42%192.24K | -14.06%277.14K |
| Other net revenue | 155.11%51.57M | -19.10%17.09M | 55.13%16.67M | -77.44%42.29M | -90.81%20.21M | -15.72%21.13M | -0.36%10.75M | 2,201.08%187.46M | 3,682.29%219.86M | 824.11%25.07M |
| Fair value change income | -30.46%50.54K | 97.10%136.79K | ---- | 177.40%49.1K | 225.90%72.67K | 220.23%69.4K | ---- | -150.03%-63.43K | -130.96%-57.72K | -121.87%-57.72K |
| Invest income | 735.57%41.98M | -33.72%4.73M | 297.69%2.46M | -102.32%-3.85M | -97.43%5.02M | 1,653.85%7.13M | 34.62%-1.25M | 1,833.68%166.25M | 20,956.61%195.54M | 177.92%406.68K |
| -Including: Investment income associates | 44.44%-2.19M | 14.80%-1.72M | 13.16%-1.37M | 12.52%-4.18M | -90.33%-3.95M | -4.53%-2.02M | -186.23%-1.58M | -228.57%-4.78M | -16.11%-2.07M | -111.99%-1.93M |
| Asset deal income | 292.17%790.93K | 336.23%790.93K | 443.06%249.49K | 1,375.80%11.53M | -243.82%-411.58K | -141.45%-334.81K | -109.36%-72.73K | -1,168.11%-903.53K | -1,630.10%-119.71K | --807.79K |
| Other revenue | 84.38%23.15M | 68.89%19.37M | 127.22%17.15M | -14.14%39.46M | -60.20%12.55M | -61.01%11.47M | -47.65%7.55M | 166.94%45.96M | 745.45%31.54M | 1,041.16%29.41M |
| Adjusted Items effecting operating profit | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 56.28%249.02M | 26.86%154.8M | 22.81%79M | -40.84%196.45M | -42.50%159.34M | 85.43%122.03M | 71.38%64.33M | 233.06%332.04M | 236.19%277.08M | 17.75%65.81M |
| Add:Non operating Income | 273.82%1.39M | 132.11%748.31K | -98.75%111.08K | 1,614.49%8.55M | -52.68%370.87K | -21.04%322.39K | 3,316.03%8.86M | 2.78%498.88K | 16.60%783.78K | 39.09%408.31K |
| Less:Non operating expense | -64.56%422.17K | -66.57%347.81K | -86.03%125.27K | -72.15%1.66M | -79.56%1.19M | -75.45%1.04M | -54.89%896.75K | -36.48%5.96M | -8.06%5.83M | 38.12%4.24M |
| Total profit | 57.70%249.98M | 27.94%155.2M | 9.25%78.99M | -37.74%203.34M | -41.73%158.51M | 95.72%121.31M | 101.91%72.3M | 259.70%326.57M | 254.43%272.04M | 16.69%61.98M |
| Less:Income tax cost | 26.20%22.58M | 28.36%19.56M | 15.80%10.73M | -52.45%23.71M | -42.23%17.9M | 20.10%15.24M | 107.47%9.26M | 138.95%49.87M | 127.51%30.97M | 37.19%12.69M |
| Add:Adjusted items effecting net profit | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit | 61.71%227.4M | 27.88%135.64M | 8.29%68.26M | -35.08%179.62M | -41.67%140.62M | 115.19%106.07M | 101.12%63.04M | 295.74%276.71M | 281.80%241.06M | 12.37%49.29M |
| Net profit from continuing operation | 61.71%227.4M | 27.88%135.64M | 8.29%68.26M | -35.08%179.62M | -41.67%140.62M | 115.19%106.07M | 101.12%63.04M | 295.74%276.71M | 281.80%241.06M | 12.37%49.29M |
| Less:Minority Profit | 46.22%-741.76K | -86.41%-1.21M | -157.17%-1.93M | 21.30%-7.2M | 92.50%-1.38M | 95.35%-646.43K | 73.86%-749.68K | -7,563.90%-9.15M | -1,954.14%-18.4M | -1,039.89%-13.91M |
| Net profit of parent company owners | 60.66%228.14M | 28.23%136.84M | 10.04%70.19M | -34.64%186.82M | -45.27%142M | 68.86%106.71M | 86.45%63.79M | 308.13%285.85M | 317.50%259.46M | 49.10%63.2M |
| Add:Adjusted items effecting net profit of parent company owners | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning per share | ||||||||||
| Basic earning per share | 60.61%0.53 | 28.00%0.32 | 6.67%0.16 | -34.85%0.43 | -45.00%0.33 | 66.67%0.25 | 87.50%0.15 | 312.50%0.66 | 328.57%0.6 | 50.00%0.15 |
| Diluted earning per share | 57.58%0.52 | 28.00%0.32 | 6.67%0.16 | -36.36%0.42 | -45.00%0.33 | 66.67%0.25 | 87.50%0.15 | 312.50%0.66 | 328.57%0.6 | 50.00%0.15 |
| Other composite income | ||||||||||
| Total composite income | 61.71%227.4M | 27.88%135.64M | 8.29%68.26M | -35.08%179.62M | -41.67%140.62M | 115.19%106.07M | 101.12%63.04M | 295.59%276.71M | 281.64%241.06M | 12.21%49.29M |
| Total composite income of parent company owners | 60.66%228.14M | 28.23%136.84M | 10.04%70.19M | -34.64%186.82M | -45.27%142M | 68.86%106.71M | 86.45%63.79M | 307.97%285.85M | 317.33%259.46M | 48.87%63.2M |
| Total composite income of minority owners | 46.22%-741.76K | -86.41%-1.21M | -157.17%-1.93M | 21.30%-7.2M | 92.50%-1.38M | 95.35%-646.43K | 73.86%-749.68K | -7,563.90%-9.15M | -1,954.14%-18.4M | -1,039.89%-13.91M |
| Add:Adjusted items effecting total composite income | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
